PAYCHEX INC
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Why Paychex Stock Slumped This Week
Revenue continued to grow for Paychex, but at a much slower rate than last year.
Thatch Raises $108M at $1B Valuation as Employers Shift Away From Traditional Health Plans
Thatch, the health benefits platform helping employers move from traditional group health plans to a consumer-directed model, today announced that it has raised $108 million in new funding at a $1 billion valuation from The General Partnership, Index Ventures, General Catalyst, and Andreessen Horowitz, with participation from ADP Ventures, Paychex, Eli Lilly and Company, Scale Venture Partners, QuantumLight, SemperVirens, Quiet Capital, and Avid Ventures.
Paychex Schedules First Quarter Fiscal 2027 Earnings Conference Call on September 23, 2026
ROCHESTER, N.Y., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Paychex, Inc. (Nasdaq: PAYX), a leading provider of expert-enabled HR, payroll, and benefits, today announced that it is scheduled to release financial results for its fiscal 2027 first quarter ended August 31, 2026 on Wednesday, September 23, 2026, before the financial markets open. The company will host a conference call at 9:30 a.m. ET on Wednesday, September 23, 2026 to discuss these results. Participating in this call will be John Gibson,
Is Paychex Stock Underperforming the S&P 500?
Paychex has lagged the S&P 500 over the past year, and the stock’s recent recovery has yet to change Wall Street’s cautious stance on its longer-term growth prospects.
Stifel Maintains Hold on Paychex, Raises Price Target to $130
Stifel analyst David Grossman maintains Paychex (NASDAQ:PAYX) with a Hold and raises the price target from $110 to $130.
Wells Fargo Maintains Underweight on Paychex, Raises Price Target to $111
Wells Fargo analyst Jason Kupferberg maintains Paychex (NASDAQ:PAYX) with a Underweight and raises the price target from $95 to $111.
The Toughest Questions PAYX Faced On Its Latest Call
Paychex is telling a story of accelerating growth, but on its latest earnings call, analysts tested whether that growth is built to last or just clever acquisition math.
Here's Why You Should Retain Paychex Stock in Your Portfolio
PAYX outpaces its industry with improving small-business hiring, AI expansion and workplace recognition, supporting a growth outlook.
Beat the Market the Zacks Way: PDF Solutions, LifeStance Health, Paychex in Focus
Zacks highlights PDF Solutions, LifeStance Health and Paychex among stocks and portfolios that outperformed as markets weighed softer jobs data and earnings.
New Jobs Keep Climbing, Ride The Wave With Paychex
Paychex stock is rated a "Buy" as it looks 32% undervalued. Here's what investors need to know about PAYX's potential upside.
Congressional Trades in $PAYX
Insider Trades (Form 4)
JOSEPH PAMELA A
VELLI JOSEPH M
DOODY JOSEPH
Simmons Christopher C
MUCCI MARTIN
Schrader Robert L.
Hansen J. Michael
Payton Theresa M.
Key People
Simmons Christopher C
VP, Controller & Treasurer
Price Kevin A
Director
GOLISANO B THOMAS
10% Owner
DOODY JOSEPH
Director
ANTE ADAM BROOKS
Sr. Vice President, Paycor
Roaldsen Elizabeth
Sr. Vice President
Schrader Robert L
Sr. VP, CFO
Bhandari Prabha S
Chief Legal Officer, Secretary
MUCCI MARTIN
Director
TUCCI JOSEPH M
Director
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro